In Vitro Lung Model Market Scope And Analysis

  • Report Code : TIPRE00006695
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

In-Vitro Lung Model Market Scope and Key Players Analysis by 2031

Buy Now

In-Vitro Lung Model Market Report In-Vitro Lung Model Market Size and Share In-Vitro Lung Model Market Scope and Analysis

In-Vitro Lung Model Market Report Scope

Report Attribute Details
Market size in 2021 US$ 405.4 Million
Market Size by 2031 US$ 1,194.4 Million
Global CAGR (2023 - 2031) 12.0%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Type
  • 2D and 3D
By Application
  • Drug Screening
  • Toxicology
  • 3D Model Development
  • Physiological Research
  • Stem Cell Research
  • Regenerative Medicine
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Epithelix Sarl
  • MATTEK
  • Lonza
  • Insphero
  • Emulate Inc
  • AlveoliX AG
  • Thermo Fisher Scientific Inc
  • PromoCell GmbH
  • Merck KgaA
  • Horizon Discovery Group plc

    • In-Vitro Lung ModelMarket News and Recent Developments

    The In-Vitro Lung ModelMarket is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in them market for In-Vitro Lung Model and strategies:

    • In December 2021, Lonza announced collaboration with Agilent Technologies Inc. and development of innovative analytical technologies with "Lonza's Cocoon Platform". The partnership seeks to advance the incorporation of existing and novel analytical methods to manufacture workflow of patient-scale cell therapies using the Cocoon Platform. Therefore, companies through collaboration will move forward in creating sustainable technologies and solutions enhancing the availability of crucial cell-based therapies for diverse lung disease.

    In-Vitro Lung ModelMarket Report Coverage and Deliverables

    The “In-Vitro Lung ModelMarket Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles